The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Portrait of Ana Nordberg. Photo.

Ana Nordberg

Senior lecturer

Portrait of Ana Nordberg. Photo.

Governing, protecting, and regulating the future of genome editing : The significance of ELSI perspectives

Author

  • Santa Slokenberga
  • Ana Nordberg
  • Timo Minssen

Summary, in English

With the recent breakthroughs in genomics and advances in genome-editing techniques, most notably the discovery of the clustered regularly interspaced short palindromic repeats (CRISPR)‑associated protein 9 (Cas9), the matter of genome editing and health innovation has become of particular importance in society. New genome-editing techniques hold considerable potential to enhance personalized medicine and deliver cures to conditions and diseases that currently cannot be tackled. However, considerable work remains to be done in order to realize this potential.

Department/s

  • Department of Law
  • Health Law

Publishing year

2022-04-08

Language

English

Pages

1-14

Publication/Series

European Journal of Health Law

Document type

Journal article

Publisher

Brill

Topic

  • Law

Keywords

  • Medical law
  • Precision medicine law
  • Genome editing governance
  • Jurisprudence
  • Medicinsk rätt
  • Allmän rättslära

Status

Epub

Research group

  • Health Law

ISBN/ISSN/Other

  • ISSN: 0929-0273